Cargando…
An acidic oligopeptide displayed on AAV2 improves axial muscle tropism after systemic delivery
BACKGROUND: The appropriate tropism of adeno-associated virus (AAV) vectors that are systemically injected is crucial for successful gene therapy when local injection is not practical. Acidic oligopeptides have been shown to enhance drug delivery to bones. METHODS: In this study six-L aspartic acids...
Autores principales: | Lee, Ni-Chung, Falk, Darin J, Byrne, Barry J, Conlon, Thomas J, Clement, Nathalie, Porvasnik, Stacy, Jorgensen, Marda L, Potter, Mark, Erger, Kirsten E, Watson, Rachael, Ghivizzani, Steven C, Chiu, Hung-Chuan, Chien, Yin-Hsiu, Hwu, Wuh-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416570/ https://www.ncbi.nlm.nih.gov/pubmed/22709483 http://dx.doi.org/10.1186/1479-0556-10-3 |
Ejemplares similares
-
AAV Gene Therapy Utilizing Glycosylation-Independent Lysosomal Targeting Tagged GAA in the Hypoglossal Motor System of Pompe Mice
por: Doyle, Brendan M., et al.
Publicado: (2019) -
A muscle-targeting peptide displayed on AAV2 improves muscle tropism upon systemic delivery
por: Yu, Chi-Yi, et al.
Publicado: (2009) -
B-cell depletion is protective against anti-AAV capsid immune response: a human subject case study
por: Corti, M, et al.
Publicado: (2014) -
AAV Engineering for Improving Tropism to the Central Nervous System
por: Ghauri, Muhammad S., et al.
Publicado: (2023) -
The hunt for novel AAV capsids with improved cardiac tropism
por: Miguel-dos-Santos, Rodrigo, et al.
Publicado: (2023)